Subscribe to RSS
DOI: 10.1055/s-2004-821223
© Georg Thieme Verlag KG Stuttgart · New York
Effects of Acute Salbutamol Intake During a Wingate Test
Publication History
Accepted after revision: May 20, 2004
Publication Date:
27 September 2004 (online)

Abstract
To investigate the impact of acute salbutamol intake on performance and selected hormonal and metabolic variables during supramaximal exercise, 13 recreational male athletes performed two 30-second Wingate tests after either placebo (PLA, lactose) or salbutamol (SAL, 4 mg) oral administration, according to a double-blind and randomized protocol. Blood samples collected at rest, end of the Wingate test, recovery (5, 10, 15 min) were tested for growth hormone (GH), insulin (INS), blood glucose (GLU), and lactate determination. We found the peak and mean power performed significantly increased after SAL vs. PLA (PPSAL: 896 ± 46; PPPLA: 819 ± 57 W; MPSAL: 585 ± 27; MPPLA: 534 ± 35 W, p < 0.05), whereas no change was observed in the fatigue index. Blood glucose and INS were significantly increased by SAL at rest, at the end of the Wingate test, and during the 5 first minutes of recovery (p < 0.05). Plasma GH was significantly decreased by SAL (p < 0.05) during the recovery whereas end-exercise and recovery blood lactate tended but were not significantly increased after SAL vs. PLA. From these data, acute salbutamol intake at therapeutical dosage did appear to improve peak power and mean power during a supramaximal exercise, but the mechanisms involved need further investigation.
Key words
β2-agonist - acute intake - performance - supramaximal exercise - hormone - lactate
References
- 1 Caswell A, Baker S, Boyd H, Potter L, Garcia M. β-adrenergic receptor and adenylate cyclase in transverse tubules of skeletal muscles. J Biol Chem. 1978; 253 3049-3054
- 2 Collomp K, Candau R, Collomp R, Carra J, Lasne F, Préfaut C, De Ceaurriz J. Effects of acute ingestion of salbutamol during submaximal exercise. Int J Sports Med. 2000; 21 480-484
- 3 Collomp K, Candau R, Millet G, Mucci P, Borrani F, Préfaut C, De Ceaurriz J. Effects of salbutamol and caffeine ingestion on exercise metabolism and performance. Int J Sports Med. 2002; 23 549-554
- 4 Giustina A, Malerba M, Bresciani E, Desenzani P, Licini M, Zaltieri G, Grassi V. Effect of two β2-agonist drugs, salbutamol and broxaterol, on the growth hormone response to exercise in adult patients with asthmatic bronchitis. J Endocrinol Invest. 1995; 18 847-852
- 5 Goldberg R, Van As M, Joffe B, Krut L, Bersohn I, Seftel H. Metabolic responses to selective β adrenergic stimulation in man. Postgrad Med J. 1975; 51 53-58
- 6 Gonzalez-Serratos H, Hill L, Valle-Aguilera R. Effects of catecholamines and cyclic AMP on excitation-contraction coupling in isolated skeletal muscle fibers of the frog. J Physiol. 1981; 315 267-282
- 7 International Olympic Committee and WADA list of doping classes and methods. 2003
- 8 Krieger D, Allen W, Rossi F, Krieger H. Characterization of the normal temporal pattern of plasma corticosteroid levels. J Clin Endocrinol Metab. 1971; 32 266-284
- 9 Lefkowitz R, de Lean A, Hoffmann B, Stadel J, Kent R. Molecular pharmacology of adenylate cyclase coupled- and β-adrenergic receptors. Adv Cyclic Nucleotide Res. 1981; 14 145-161
- 10 Lemmer J, Fleck S, Wallach J, Fox S, Burke E, Kearney J, Storms W. The effects of albuterol on power output in non-asthmatic athletes. Int J Sports Med. 1995; 16 243-249
- 11 Linossier M, Denis C, Dormois D, Geyssant A, Lacour J R. Ergometric and metabolic adaptation to a 5-s sprint training programme. Eur J Appl Physiol. 1993; 67 408-414
- 12 Price A, Clissold S. Salbutamol in the 1980s. A reappraisal of its clinical efficacy. Drugs. 1989; 38 77-122
- 13 Reeds P, Hay S, Dorward P, Palmer R. The effects of β-agonists and antagonists on muscle growth and body composition of young rats. Comp Biochem Physiol. 1988; 89 337-341
- 14 Ricks C, Dalrymple R, Baker P, Ingle D. Use of a β-agonist to alter fat and muscle deposition in steers. J Anim Sci. 1984; 59 1247-1255
- 15 Rolf Smith S, Kendall M. Metabolic responses to β2 stimulants. J R Coll Chest Physiol. 1984; 18 190-194
- 16 Schaub C, Bluet Pajot M, Partouche R. The effects of β adrenergic receptor agonist salbutamol on growth-hormone release in the rhesus monkey. IRCS Med Sci. 1983; 11 832-833
- 17 Signorile J, Kaplan T, Applegate B, Perry A. Effects of acute inhalation of the bronchodilator, albuterol, on power output. Med Sci Sports Exerc. 1992; 24 638-642
- 18 Smith A, Banks J, Buchenen K, Cheong B, Gunawardena K. Mechanisms of abnormal glucose metabolism during the treatment of acute severe asthma. Q J Med. 1992; 82 71-80
- 19 Van Baak M, Mayer L, Kempinski R, Hartgens F. Effect of salbutamol on muscle strength and endurance performance in nonasthmatic men. Med Sci Sports Exerc. 2000; 32 1300-1306
- 20 Wager J, Fredholm B, Lunell N, Persson B. Metabolic and circulatory effects of intravenous and oral salbutamol in late pregnancy in diabetic and non diabetic women. Acta Obstet Gynaecol Scand. 1982; 108 41-46
Katia Collomp
Laboratoire de la Performance Motrice, Faculté du Sport et de l'Education Physique
Rue de Vendôme, BP 6237
45062 Orléans Cedex 2
France
Phone: + 0238417178
Fax: + 02 38 41 72 60
Email: katia.collomp@univ-orleans.fr